Jeffrey H. Burbank is the Founder, Chief Executive Officer and is a member of the board of directors at NxStage Medical, Inc. He has more than 20 years of in-depth management experience with companies developing, marketing and manufacturing products for end-stage renal disease patients. Mr. Burbank has led NxStage since its inception, guiding it through all of its developmental phases to the successful initiation and rapid growth of commercial activities, its initial public offering and the acquisition of Medisystems. Before founding NxStage, he cofounded Vasca, Inc., a company providing innovative implantable access devices, where he was the President and CEO, as well as Chairman of the board. Mr. Burbank gained significant renal industry experience during his nine years in the renal division at Gambro, Inc., with his last position as Director of Marketing and Advanced Technologies. During his career, Mr. Burbank has been an inventor on more than 50 U.S. patents for medical devices. He received his B.S. in industrial engineering from Lehigh University.
NxStage Medical, Inc. (NXTM)
July 18, 2012